162 related articles for article (PubMed ID: 26266831)
41. Manganese chloride-induced G0/G1 and S phase arrest in A549 cells.
Zhao P; Zhong W; Ying X; Yuan Z; Fu J; Zhou Z
Toxicology; 2008 Aug; 250(1):39-46. PubMed ID: 18577415
[TBL] [Abstract][Full Text] [Related]
42. Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells.
Yang TY; Chang GC; Chen KC; Hung HW; Hsu KH; Sheu GT; Hsu SL
Eur J Pharmacol; 2011 Aug; 663(1-3):17-26. PubMed ID: 21575631
[TBL] [Abstract][Full Text] [Related]
43. The T-box transcription factor TBX3 drives proliferation by direct repression of the p21(WAF1) cyclin-dependent kinase inhibitor.
Willmer T; Hare S; Peres J; Prince S
Cell Div; 2016; 11():6. PubMed ID: 27110270
[TBL] [Abstract][Full Text] [Related]
44. Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species.
Havens CG; Ho A; Yoshioka N; Dowdy SF
Mol Cell Biol; 2006 Jun; 26(12):4701-11. PubMed ID: 16738333
[TBL] [Abstract][Full Text] [Related]
45. Cardiotonic steroids attenuate ERK phosphorylation and generate cell cycle arrest to block human hepatoma cell growth.
Xu ZW; Wang FM; Gao MJ; Chen XY; Shan NN; Cheng SX; Mai X; Zala GH; Hu WL; Xu RC
J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):181-91. PubMed ID: 21215801
[TBL] [Abstract][Full Text] [Related]
46. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.
Du J; Widlund HR; Horstmann MA; Ramaswamy S; Ross K; Huber WE; Nishimura EK; Golub TR; Fisher DE
Cancer Cell; 2004 Dec; 6(6):565-76. PubMed ID: 15607961
[TBL] [Abstract][Full Text] [Related]
47. Reduced activity and cytoplasmic localization of Runx2 is observed in C3h10t1/2 cells overexpressing Tbx3.
Deepak V; Zhang Z; Meng L; Zeng X; Liu W
Cell Biochem Funct; 2011 Jun; 29(4):348-50. PubMed ID: 21455926
[TBL] [Abstract][Full Text] [Related]
48. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
49. A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome.
Carlson H; Ota S; Campbell CE; Hurlin PJ
Hum Mol Genet; 2001 Oct; 10(21):2403-13. PubMed ID: 11689487
[TBL] [Abstract][Full Text] [Related]
50. Total saponins of Albiziae Cortex show anti-hepatoma carcinoma effects by inducing S phase arrest and mitochondrial apoptosis pathway activation.
Qian Y; Han QH; Wang LC; Guo Q; Wang XD; Tu PF; Zeng KW; Liang H
J Ethnopharmacol; 2018 Jul; 221():20-29. PubMed ID: 29655853
[TBL] [Abstract][Full Text] [Related]
51. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
52. Double identity of SCAPER: a substrate and regulator of cyclin A/Cdk2.
Tsang WY; Dynlacht BD
Cell Cycle; 2008 Mar; 7(6):702-5. PubMed ID: 18245951
[TBL] [Abstract][Full Text] [Related]
53. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
54. Basal transcription of the human TBX3 gene, a key developmental regulator which is overexpressed in several cancers, requires functional NF-Y and Sp1 sites.
Smith J; Mowla S; Prince S
Gene; 2011 Oct; 486(1-2):41-6. PubMed ID: 21784138
[TBL] [Abstract][Full Text] [Related]
55. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
56. [E1A oncogene effect on the ability of p21(Waf1) to regulate G1/S arrest in E1A-expressing transformants following irradiation].
Romanov VS; Brichkina AI; Pospelov VA; Pospelova TV
Tsitologiia; 2005; 47(12):1063-70. PubMed ID: 16706194
[TBL] [Abstract][Full Text] [Related]
57. Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43.
Boogerd KJ; Wong LY; Christoffels VM; Klarenbeek M; Ruijter JM; Moorman AF; Barnett P
Cardiovasc Res; 2008 Jun; 78(3):485-93. PubMed ID: 18285513
[TBL] [Abstract][Full Text] [Related]
58. TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.
Yarosh W; Barrientos T; Esmailpour T; Lin L; Carpenter PM; Osann K; Anton-Culver H; Huang T
Cancer Res; 2008 Feb; 68(3):693-9. PubMed ID: 18245468
[TBL] [Abstract][Full Text] [Related]
59. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
Sakurikar N; Thompson R; Montano R; Eastman A
Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
[TBL] [Abstract][Full Text] [Related]
60. PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration.
Mowla S; Pinnock R; Leaner VD; Goding CR; Prince S
Biochem J; 2011 Jan; 433(1):145-53. PubMed ID: 20942798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]